Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians.

Publication ,  Journal Article
Viera, AJ; Sheridan, SL; Edwards, T; Soliman, EZ; Harris, R; Furberg, CD
Published in: Prev Med
January 2011

OBJECTIVE: To examine US physicians' self-reported knowledge about the Polypill, factors considered in deciding whether to prescribe it, and acceptance of prescribing it for cardiovascular disease (CVD) prevention. METHODS: Numerical scales of 0 (lowest) to 5 (highest) were used to assess self-reported knowledge and importance of factors relevant to making a decision to prescribe a Polypill. Characteristics of physicians indicating they would prescribe a Polypill were compared. RESULTS: Among 952 physicians surveyed February through March 2010, mean self-rated knowledge about the Polypill was 2.0±1.5. Importance of degree of CVD event reduction, cost, and side effects were rated with means of 4.4, 4.3, and 4.3, respectively. 83% of respondents indicated they would "definitely" or "probably" prescribe it for high-risk patients; 62% would do so for moderate risk patients. Physicians with self-rated knowledge at ≥75th percentile were more likely to indicate they would prescribe a Polypill for moderate risk (adjusted OR 2.16; 95% CI 1.60-2.93) and high-risk (adjusted OR 1.57; 95% CI 1.07-2.32) patients. CONCLUSION: Among this sample of physicians, there is relatively high acceptance of prescribing a Polypill for CVD prevention despite relatively modest knowledge about it.

Duke Scholars

Published In

Prev Med

DOI

EISSN

1096-0260

Publication Date

January 2011

Volume

52

Issue

1

Start / End Page

10 / 15

Location

United States

Related Subject Headings

  • United States
  • Public Health
  • Primary Prevention
  • Practice Patterns, Physicians'
  • Platelet Aggregation Inhibitors
  • Male
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Hematinics
  • Health Knowledge, Attitudes, Practice
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Viera, A. J., Sheridan, S. L., Edwards, T., Soliman, E. Z., Harris, R., & Furberg, C. D. (2011). Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians. Prev Med, 52(1), 10–15. https://doi.org/10.1016/j.ypmed.2010.09.016
Viera, Anthony J., Stacey L. Sheridan, Teresa Edwards, Elsayed Z. Soliman, Russell Harris, and Curt D. Furberg. “Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians.Prev Med 52, no. 1 (January 2011): 10–15. https://doi.org/10.1016/j.ypmed.2010.09.016.
Viera AJ, Sheridan SL, Edwards T, Soliman EZ, Harris R, Furberg CD. Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians. Prev Med. 2011 Jan;52(1):10–5.
Viera, Anthony J., et al. “Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians.Prev Med, vol. 52, no. 1, Jan. 2011, pp. 10–15. Pubmed, doi:10.1016/j.ypmed.2010.09.016.
Viera AJ, Sheridan SL, Edwards T, Soliman EZ, Harris R, Furberg CD. Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians. Prev Med. 2011 Jan;52(1):10–15.
Journal cover image

Published In

Prev Med

DOI

EISSN

1096-0260

Publication Date

January 2011

Volume

52

Issue

1

Start / End Page

10 / 15

Location

United States

Related Subject Headings

  • United States
  • Public Health
  • Primary Prevention
  • Practice Patterns, Physicians'
  • Platelet Aggregation Inhibitors
  • Male
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Hematinics
  • Health Knowledge, Attitudes, Practice